Geode Capital Management, LLC Icosavax, Inc. Transaction History

Geode Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$5.95 - $15.79 $172,210 - $457,009	28,943 Added 4.25%	709,322 $11.2 Million
Q3 2023 Nov 13, 2023	BUY	$7.22 - $10.05 $1.33 Million - $1.85 Million	184,548 Added 37.22%	680,379 $5.27 Million
Q2 2023 Aug 11, 2023	BUY	$4.89 - $10.57 $374,290 - $809,048	76,542 Added 18.26%	495,831 $4.92 Million
Q1 2023 May 15, 2023	BUY	$5.62 - $11.51 $179,542 - $367,709	31,947 Added 8.25%	419,289 $2.43 Million
Q4 2022 Feb 13, 2023	BUY	$2.32 - $10.97 $48,965 - $231,532	21,106 Added 5.76%	387,342 $3.08 Million
Q3 2022 Nov 14, 2022	BUY	$3.09 - $9.21 $93,905 - $279,891	30,390 Added 9.05%	366,236 $1.16 Million
Q2 2022 Aug 12, 2022	BUY	$5.7 - $10.33 $95,326 - $172,758	16,724 Added 5.24%	335,846 $1.92 Million
Q1 2022 May 13, 2022	BUY	$4.41 - $22.5 $399,876 - $2.04 Million	90,675 Added 39.69%	319,122 $2.25 Million
Q4 2021 Feb 11, 2022	BUY	$21.07 - $34.98 $226,671 - $376,314	10,758 Added 4.94%	228,447 $5.23 Million
Q3 2021 Nov 12, 2021	BUY	$24.85 - $40.25 $5.41 Million - $8.76 Million	217,689 New	217,689 $6.44 Million

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.